Personalized supplements and weight-loss program

$32 million judgment (partially suspended) / Prohibited from making claims that a product or program causes substantial or permanent weight-loss or fat loss, or cures, mitigates, or treats any disease unless substantiated by competent and reliable scientific evidence that is sufficient in quality and quantity based on standards accepted by experts in the relevant disease, condition, or function to which the representation relates / Such testing shall be randomized, double-blind, and placebo-controlled and conducted by researchers qualified to conduct such testing / Must disclose whether a program requires a restricted diet and physician monitoring / Prohibited from using deceptive endorsements and must disclose material connections / Prohibited from using non-disparagement clauses in contracts / Other weight-loss or health-related claims must be supported by competent and reliable scientific evidence conducted and evaluated by experts in the relevant disease, condition, or function to which the representation relates, and must be randomized, double-blind, and placebo-controlled when required by such experts